Chugai Pharmaceutical Co Ltd (CUP): aksiya narxi va yangiliklar

CUP:FRA

Chugai Pharmaceutical Co Ltd

40,26 €

+2,26%

(+0,89) 1K

24-iyn, 9:55:02 (GMT+2) · EUR

Barcha belgilar

YBB

MAKS

	Belgi	Narxi	Oʻzgartirishlar	Dinamika (%)

CUP tikeri uchun statistika yaratilmoqda...

Ochish

40,37 €

Yuqori

40,37 €

Past

40,26 €

Bozor kapitali

12,59 trln

Oʻrtacha hajm

70,00

Hajmi

0,00

52 haftalik eng yuqori

56,26 €

52 haftalik eng past

33,02 €

Xodimlar soni

5 ming

Ochish

40,37 €

Yuqori

40,37 €

Past

40,26 €

Bozor kapitali

12,59 trln

Oʻrtacha hajm

70,00

Hajmi

0,00

52 haftalik eng yuqori

56,26 €

52 haftalik eng past

33,02 €

Xodimlar soni

5 ming

Aloqador aksiyalar

Canadian National Railway Co

100,45 €

-0,64%

BMD

Baronsmead Second Venture Trust PLC

46,98 GBX

+0,82%

Yangiliklar

Internetdagi manbalardan

Business Wire

40 daqiqa oldin

Powerlaw Corp. (Nasdaq: PWRL) Highlights Kalshi Portfolio Holding, Following Reports of $2B Annualized Revenue

Barron's

41 daqiqa oldin

S.Korea Chip Giant SK Hynix Seeks $29 Bn In Nasdaq Listing: Regulatory Filing

Seeking Alpha

15 daqiqa oldin

AM Markets Need to Know: Alphabet in Dow, Alibaba sues U.S. government, and more (SP500:)

The Motley Fool

51 daqiqa oldin

The S&P 500 Is Up 9% in 2026. Wall Street Says the Stock Market Will Do This Next.

Profil

Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia

Chugai Pharmaceutical Co Ltd haqida

CEOOsamu Okuda

Xodimlar soni5,1 ming

Asos solingan10-mar, 1925

Bosh ofislar-

Sektor-

Veb-saytchugai-pharm.co.jp

Barcha qiymatlar – JPY	iyn, 2025	sen, 2025	dek, 2025	mar, 2026
Daromad	290,00 mlrd	333,18 mlrd	346,30 mlrd	321,75 mlrd
Sotilgan mahsulotning tannarxi	88,07 mlrd	100,24 mlrd	87,56 mlrd	92,79 mlrd
Daromad narxi	88,07 mlrd	100,24 mlrd	87,56 mlrd	92,79 mlrd
Tadqiqot va ishlanmalarga xarajatlar	45,66 mlrd	48,60 mlrd	52,41 mlrd	41,89 mlrd
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar	-	-	-	-
Tijoriy, umumiy va maʼmuriy xarajatlar	28,41 mlrd	27,89 mlrd	36,92 mlrd	28,90 mlrd
Operatsion xarajatlar	65,24 mlrd	76,45 mlrd	89,74 mlrd	70,19 mlrd
Jami operatsion xarajatlar	153,31 mlrd	176,69 mlrd	177,30 mlrd	162,98 mlrd
Operatsion daromad	136,69 mlrd	156,48 mlrd	169,01 mlrd	158,76 mlrd
Boshqa nooperatsion daromad	-636,00 mln	-356,00 mln	994,00 mln	1,43 mlrd
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar	136,00 mlrd	156,07 mlrd	169,90 mlrd	160,20 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno	136,00 mlrd	156,07 mlrd	169,90 mlrd	160,20 mlrd
Daromad soligʻi boʻyicha xarajat	38,85 mlrd	44,86 mlrd	41,50 mlrd	44,78 mlrd
Amaldagi soliq stavkasi	28,56%	28,74%	24,42%	27,95%
Boshqa operatsion xarajatlar	-8,83 mlrd	-38,00 mln	405,00 mln	-596,00 mln
Sof foyda	97,16 mlrd	111,21 mlrd	128,41 mlrd	115,42 mlrd
Sof foyda marjasi	33,50%	33,38%	37,08%	35,87%
Har bir aksiya foydasi	-	-	-	-
Foizlar va investitsiyalardan olingan daromadlar	-	-	-	-
Foizlarni toʻlash xarajatlari	-54,00 mln	-58,00 mln	-95,00 mln	-
Foizlarni toʻlash boʻyicha sof xarajatlar	-54,00 mln	-58,00 mln	-95,00 mln	-
Amortizatsiya ajratmalari	-	-	-	-
EBITDA	137,09 mlrd	156,78 mlrd	200,44 mlrd	159,26 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar	-	-	4,53 mlrd	-

AI kontentda xatolar boʻlishi mumkin. Batafsil

YordamFikr-mulohazaMaxfiylik Shartlar Majburiyatlardan voz kechish

Finance

Tahlil